Home / Pharma Healthcare / Global Active Pharmaceutical Ingredient Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Global Active Pharmaceutical Ingredient Market by Manufacturers, Regions, Type and Application, Forecast to 2021

  • Id : RNR-44310
  • Category : Pharma Healthcare
  • Publish Date : Dec-16
  • Publisher : GlobalInfo Research
  • Pages : 112
  • Format : PDF
License Type

Description
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.

Scope of the Report:
This report focuses on the Active Pharmaceutical Ingredient in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    Teva
    Novartis
    Pfizer
    Johnson & Johnson
    Mylan
    North China Pharmaceutical Group
    Dr. Reddy?s Laboratories
    Roche
    Aurobindo pharma
    Sun Pharmaceutical Industries
    Boehringer Ingelheim GmbH
    Bayer
    BASF
    DSM
    Zhejiang Medicine
    Biocon
    Johnson Matthey
    Hisun Pharmacy
    Cambrex
    Shandong Xinhua Pharmaceutical
    Lonza group
    Huahai Pharmaceutical
    Haerbin Pharmaceutical Group
    Cipla
    Tian Yao
    Lupin
    North East Pharmaceutical
    Albemarle
    Shandong Lukang Pharmaceutical
    Jiangsu Hengrui Medicine
    Bachem

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
    Synthetic API
    Biotech API
    Other

Market Segment by Applications, can be divided into
    Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    Oncology Drugs
    Anti-diabetic Drugs
    Cardiovascular Drugs
    Central Nervous System Drugs (CNS Drugs)
    Musculoskeletal Drugs
    Other Drugs

There are 13 Chapters to deeply display the global Active Pharmaceutical Ingredient market.

Chapter 1, to describe Active Pharmaceutical Ingredient Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Active Pharmaceutical Ingredient, with sales, revenue, and price of Active Pharmaceutical Ingredient, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Active Pharmaceutical Ingredient, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Active Pharmaceutical Ingredient market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Active Pharmaceutical Ingredient sales channel, distributors, traders, dealers, appendix and data source.